Beyond direct genetic testing, AGU patients can be reliably identified by AGA enzyme activity measurements in the serum [26], whereas for NGLY1 deficiency, no easy-to-perform routine enzyme activity test is available. The gene discussed is NGLY1; the disease is aspartylglucosaminuria.